Redeye: Corline Biomedical - Kardium receives FDA approval


2 september, 10:29

Redeye is positive about Kardium’s FDA approval for the Globe system, which allows the commercial phase to begin. As our previous sales projections were risk-adjusted, we now make some changes to our forecasts. These revisions result in an updated fair value range for Corline.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Corline Biomedical - Kardium receives FDA approval

Läs mer på MFN



Marknadsöversikt

1 DAG %

Senast

1 mån